WDC, FLS, KAR, AU and JBL show strong relative price strength as trade deals and economic data fuel the S&P 500 rally.

NUE is expected to post strong Q2 as tariff-fueled steel price spikes and higher volumes are likely to lift performance.

West Bancorp (WTBA) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.31 per share a year ago.

LITTLE ROCK, Ark. , July 24, 2025 /PRNewswire/ -- Tickets for the Simmons Bank Championship presented by Stephens—a PGA TOUR Champions playoff event—are now on sale to the public.

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)---- $NRGV--Energy Vault Holdings Inc. (NYSE: NRGV) (“Energy Vault” or the “Company”), a leader in sustainable, grid-scale energy storage solutions, today announced the successful close of $18 million in project financing for its Cross Trails battery energy storage system (BESS). The financing marks another milestone in the Company's execution of its ‘Own & Operate' growth and asset management strategy, originally outlined during the May 2024 Investor and Anal.

JUNO BEACH, Fla. , July 24, 2025 /PRNewswire/ -- The board of directors of NextEra Energy, Inc. (NYSE: NEE) declared a regular quarterly common stock dividend of $0.5665 per share.

The presentation will include data from over 90 patients in both the plaque brachytherapy and enucleation-eligible cohorts Darovasertib has received U.S. FDA Breakthrough Therapy Designation for use in neoadjuvant uveal melanoma for subjects requiring enucleation Initiated a multi-site, global randomized Phase 3 neoadjuvant registrational trial in primary uveal melanoma (OptimUM-10) in Q3 2025 SOUTH SAN FRANCISCO, Calif. , July 24, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced that results from a multi-site global Phase 2 study of neoadjuvant darovasertib in primary uveal melanoma was accepted for a Proffered Paper oral presentation …

PALO ALTO, Calif. and NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Walrus, the decentralized data storage protocol built by Mysten Labs, the original contributors to Sui, and Veea Inc. (Nasdaq:VEEA), a leader in intelligent edge infrastructure, today announced the adoption of Walrus as a VeeaHub STAX™ edge solution to provide high-performance data transport and storage capabilities for the decentralized network.

The S&P 500 enters Thursday trading right where it left off Wednesday night — neither up nor down.

I am bullish on Novo Nordisk due to its 62% global GLP-1 market share and dominant Ozempic sales, supporting long-term leadership. Novo Nordisk's diversified GLP-1 portfolio, including Rybelsus and pending pill versions, positions it well against competitors and broadens its addressable market. Consistent double-digit revenue and profit growth, plus strong Q2 2025 expectations, reflect robust demand and effective cost management.

After a rough start to the year, tech stocks are back on top. As of this writing, the tech-heavy Nasdaq Composite is up 28% over the last three months.

SAN FRANCISCO--(BUSINESS WIRE)--AlikeAudience, a leading data science company specializing in omnichannel data activation, today announced the launch of AURAR, a groundbreaking data collaboration tool, with a native Lookalike model application now available in the Snowflake Marketplace. With AURAR, AlikeAudience is empowering marketers to prepare ideal audiences through seamless, secure, and accelerated collaboration with first-party data. The launch of AURAR addresses the fundamental shifts dr.

Candel Therapeutics Inc (NASDAQ:CADL) announced that the European Medicines Agency (EMA) has granted Orphan Designation to its investigational immunotherapy CAN-2409 for the treatment of pancreatic cancer. The designation adds to CAN-2409's existing Orphan Drug Designation and Fast Track Designation from the US Food and Drug Administration for pancreatic ductal adenocarcinoma.

UnitedHealth Group Inc. (NYSE: UNH) shares tumbled another 4% in premarket trading following the company's disclosure of a Department of Justice investigation into its Medicare program practices, adding to what has already been a disastrous year for the healthcare giant.

Here's our initial take on Novocure's (NVCR -9.99%) fiscal 2025 second-quarter financial report.

U.S. stocks are rising toward more records on Wednesday following a trade deal between the world's No. 1 and No. 4 economies, one that would lower proposed tariffs on Japanese imports coming to the United States.

Raymond James misses fiscal Q3 earnings expectations due to a $58M legal reserve. On the other hand, trading and IB strength help lift revenues.

CRGY, BHB and HII made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 24, 2025.

First Northwest Bancorp (FNWB) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.16 per share a year ago.

Dime Community (DCOM) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.37 per share a year ago.